Rhumbline Advisers Has $17.61 Million Holdings in Maximus, Inc. $MMS

Rhumbline Advisers decreased its holdings in shares of Maximus, Inc. (NYSE:MMS) by 4.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 192,773 shares of the health services provider’s stock after selling 8,590 shares during the period. Rhumbline Advisers’ holdings in Maximus were worth $17,614,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Richardson Financial Services Inc. boosted its stake in shares of Maximus by 123.1% during the 3rd quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after buying an additional 192 shares during the last quarter. Cullen Frost Bankers Inc. bought a new stake in Maximus during the third quarter worth about $38,000. Canada Pension Plan Investment Board acquired a new position in Maximus during the second quarter valued at approximately $35,000. Parkside Financial Bank & Trust grew its stake in Maximus by 21.7% in the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after purchasing an additional 157 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Maximus by 13.9% during the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock worth $122,000 after purchasing an additional 163 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Stock Performance

NYSE:MMS opened at $72.39 on Wednesday. The stock has a 50 day simple moving average of $88.73 and a 200 day simple moving average of $86.69. The stock has a market cap of $3.95 billion, a P/E ratio of 11.02 and a beta of 0.57. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $100.00. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same period in the prior year, the firm posted $1.61 EPS. The company’s revenue for the quarter was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be given a $0.33 dividend. The ex-dividend date is Friday, February 13th. This is a positive change from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. Maximus’s dividend payout ratio (DPR) is presently 20.09%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Weiss Ratings reissued a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. Wall Street Zen upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Strong Buy”.

Insider Activity at Maximus

In other news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider directly owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. This represents a 17.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO David Mutryn purchased 1,000 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The stock was bought at an average cost of $75.62 per share, with a total value of $75,620.00. Following the purchase, the chief financial officer owned 40,037 shares of the company’s stock, valued at $3,027,597.94. This represents a 2.56% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders purchased 4,231 shares of company stock worth $329,521. Company insiders own 1.80% of the company’s stock.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.